Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Aberg

Showing results (51-60 of 211) with videos related to

Pageof 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2002
Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapyJudith A Aberg, Peter V Chin-Hong, Allen McCutchan, et al.
Inflammation|May 25, 2016
Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332Ann Danoff, Michelle A Kendall, Judith S Currier, et al.
HIV Medicine|December 22, 2022
Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV-1 with suppressed HIV-1 RNA and LDL cholesterol <130 mg/dLFarah Rahman, Irena Brates, Francesca Aweeka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected personsEdgar Turner Overton, Somnuek Sungkanuparph, William G Powderly, et al.
Sexually Transmitted Infections|March 2, 2011
Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York CitySapna A Mehta, Richard Silvera, Kyle Bernstein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 4, 2014
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohortMinhee Kang, Kimberly Hollabaugh, Vinh Pham, et al.
Journal of Clinical and Translational Science|February 27, 2023
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trialFarah Rahman, Taryn McLaughlin, Pedro Mesquita, et al.
Medicine|June 1, 2018
Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332Theodoros Kelesidis, Michelle A Kendall, Ann Danoff, et al.
Open Forum Infectious Diseases|October 30, 2025
A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for the Switch to Two-Drug Antiretroviral Regimens in People With HIVMelissa Margolis, Shilpa Vasishta, Judith A Aberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2013
Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of AmericaJudith A Aberg, Joel E Gallant, Khalil G Ghanem, et al.
Pageof 22

Showing results (51-60 of 211) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2002
Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapyJudith A Aberg, Peter V Chin-Hong, Allen McCutchan, et al.
Inflammation|May 25, 2016
Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332Ann Danoff, Michelle A Kendall, Judith S Currier, et al.
HIV Medicine|December 22, 2022
Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV-1 with suppressed HIV-1 RNA and LDL cholesterol <130 mg/dLFarah Rahman, Irena Brates, Francesca Aweeka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected personsEdgar Turner Overton, Somnuek Sungkanuparph, William G Powderly, et al.
Sexually Transmitted Infections|March 2, 2011
Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York CitySapna A Mehta, Richard Silvera, Kyle Bernstein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 4, 2014
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohortMinhee Kang, Kimberly Hollabaugh, Vinh Pham, et al.
Journal of Clinical and Translational Science|February 27, 2023
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trialFarah Rahman, Taryn McLaughlin, Pedro Mesquita, et al.
Medicine|June 1, 2018
Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332Theodoros Kelesidis, Michelle A Kendall, Ann Danoff, et al.
Open Forum Infectious Diseases|October 30, 2025
A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for the Switch to Two-Drug Antiretroviral Regimens in People With HIVMelissa Margolis, Shilpa Vasishta, Judith A Aberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2013
Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of AmericaJudith A Aberg, Joel E Gallant, Khalil G Ghanem, et al.
Pageof 22